PT99250A - Processo para a preparacao de derivados de piperazina - Google Patents
Processo para a preparacao de derivados de piperazinaInfo
- Publication number
- PT99250A PT99250A PT99250A PT9925091A PT99250A PT 99250 A PT99250 A PT 99250A PT 99250 A PT99250 A PT 99250A PT 9925091 A PT9925091 A PT 9925091A PT 99250 A PT99250 A PT 99250A
- Authority
- PT
- Portugal
- Prior art keywords
- lower alkyl
- aryl
- hydrogen
- alkyl
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Quinoline Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909022821A GB9022821D0 (en) | 1990-10-19 | 1990-10-19 | Piperazine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT99250A true PT99250A (pt) | 1992-08-31 |
| PT99250B PT99250B (pt) | 1999-04-30 |
Family
ID=10684054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99250A PT99250B (pt) | 1990-10-19 | 1991-10-17 | Processo para a preparacao de derivados de piperazina |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5169845A (pt) |
| EP (1) | EP0481742B1 (pt) |
| JP (1) | JP3012048B2 (pt) |
| KR (1) | KR100193927B1 (pt) |
| AT (1) | ATE160562T1 (pt) |
| AU (1) | AU642043B2 (pt) |
| CA (1) | CA2053705C (pt) |
| DE (1) | DE69128272T2 (pt) |
| DK (1) | DK0481742T3 (pt) |
| ES (1) | ES2109936T3 (pt) |
| GB (2) | GB9022821D0 (pt) |
| GR (1) | GR3025590T3 (pt) |
| HU (2) | HU217610B (pt) |
| IE (1) | IE64632B1 (pt) |
| NZ (1) | NZ240272A (pt) |
| PT (1) | PT99250B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9022790D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
| GB9300195D0 (en) * | 1993-01-06 | 1993-03-03 | Wyeth John & Brother Ltd | Piperazine derivatives |
| GB9314758D0 (en) * | 1993-07-16 | 1993-08-25 | Wyeth John & Brother Ltd | Heterocyclic derivatives |
| US5418236A (en) * | 1993-12-23 | 1995-05-23 | Ortho Pharmaceutical Corporation | Anxiolytic aroyl piperidinyl and piperazinylacyl pyrroles |
| US5609849A (en) * | 1994-03-11 | 1997-03-11 | The Trustees Of The University Of Pennsylvania | Serotonin (5-HT1A) receptor ligands and imaging agents |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968684A (en) * | 1987-04-01 | 1990-11-06 | Janssen Pharmaceutica N.V. | Method of improving sleep |
| US4882432A (en) * | 1989-01-09 | 1989-11-21 | American Home Products Corporation | Polycyclic-carbamic acid piperazinoalkyl esters and amides |
| GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
| GB2227018B (en) * | 1989-01-13 | 1992-05-20 | Wyeth John & Brother Ltd | Piperazinylalkylcarboxylic acid adamantylamides |
| GB9021535D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
| AU644488B2 (en) * | 1990-10-19 | 1993-12-09 | John Wyeth & Brother Limited | Piperazine derivatives |
-
1990
- 1990-10-19 GB GB909022821A patent/GB9022821D0/en active Pending
-
1991
- 1991-09-30 US US07/768,146 patent/US5169845A/en not_active Expired - Lifetime
- 1991-10-16 DE DE69128272T patent/DE69128272T2/de not_active Expired - Fee Related
- 1991-10-16 EP EP91309509A patent/EP0481742B1/en not_active Expired - Lifetime
- 1991-10-16 GB GB9121944A patent/GB2254324B/en not_active Expired - Fee Related
- 1991-10-16 DK DK91309509.7T patent/DK0481742T3/da active
- 1991-10-16 ES ES91309509T patent/ES2109936T3/es not_active Expired - Lifetime
- 1991-10-16 AT AT91309509T patent/ATE160562T1/de not_active IP Right Cessation
- 1991-10-17 JP JP3269289A patent/JP3012048B2/ja not_active Expired - Fee Related
- 1991-10-17 PT PT99250A patent/PT99250B/pt active IP Right Grant
- 1991-10-17 NZ NZ240272A patent/NZ240272A/xx unknown
- 1991-10-17 AU AU85919/91A patent/AU642043B2/en not_active Ceased
- 1991-10-18 KR KR1019910018374A patent/KR100193927B1/ko not_active IP Right Cessation
- 1991-10-18 CA CA002053705A patent/CA2053705C/en not_active Expired - Fee Related
- 1991-10-18 IE IE366891A patent/IE64632B1/en not_active IP Right Cessation
- 1991-10-18 HU HU293/91A patent/HU217610B/hu not_active IP Right Cessation
-
1995
- 1995-06-27 HU HU95P/P00448P patent/HU211588A9/hu unknown
-
1997
- 1997-12-03 GR GR970403242T patent/GR3025590T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3012048B2 (ja) | 2000-02-21 |
| IE913668A1 (en) | 1992-04-22 |
| GB9022821D0 (en) | 1990-12-05 |
| IE64632B1 (en) | 1995-08-23 |
| GR3025590T3 (en) | 1998-03-31 |
| DK0481742T3 (da) | 1997-12-29 |
| EP0481742A1 (en) | 1992-04-22 |
| GB9121944D0 (en) | 1991-11-27 |
| GB2254324A (en) | 1992-10-07 |
| NZ240272A (en) | 1992-10-28 |
| AU642043B2 (en) | 1993-10-07 |
| ATE160562T1 (de) | 1997-12-15 |
| DE69128272T2 (de) | 1998-03-19 |
| AU8591991A (en) | 1992-04-30 |
| ES2109936T3 (es) | 1998-02-01 |
| KR100193927B1 (ko) | 1999-06-15 |
| EP0481742B1 (en) | 1997-11-26 |
| JPH04288073A (ja) | 1992-10-13 |
| US5169845A (en) | 1992-12-08 |
| GB2254324B (en) | 1994-06-22 |
| KR920008020A (ko) | 1992-05-27 |
| DE69128272D1 (de) | 1998-01-08 |
| HU913293D0 (en) | 1992-01-28 |
| HUT60261A (en) | 1992-08-28 |
| HU211588A9 (en) | 1995-12-28 |
| CA2053705A1 (en) | 1992-04-20 |
| PT99250B (pt) | 1999-04-30 |
| HU217610B (hu) | 2000-03-28 |
| CA2053705C (en) | 2002-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9206939A (es) | Derivados de piperazina, procedimiento para su preparacion y composicion farmaceutica que los comprende | |
| ATE144772T1 (de) | Piperazinderivate | |
| DE69122427D1 (de) | Imidazonaphthyridinderivate | |
| FI911016A0 (fi) | Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi | |
| PT99250A (pt) | Processo para a preparacao de derivados de piperazina | |
| DK0601191T3 (da) | Hidtil ukendt tetracyklisk forbindelse | |
| DE3677857D1 (de) | 2,5-dimethylpyrrolderivative, ihre herstellung und ihre verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19920422 |
|
| FG3A | Patent granted, date of granting |
Effective date: 19990107 |